Saturday, December 13, 2025 | 08:24 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Nectar Lifescience secures ANVISA (Brazil) cGMP

Image

Capital Market

For Cephalosporin API's manufacturing facility

Nectar Lifescience has received ANVISA cGMP (current good manufacturing practices) approval for Brazil for its Cephalosporin API's manufacturing facility in Dera Bassi, Punjab.

Powered by Capital Market - Live News

 

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 14 2015 | 6:31 PM IST

Explore News